In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $45.00. The company’s shares closed yesterday ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

Making the world smarter, happier, and richer.

Finished logos can be instantly downloaded in multiple formats, such as PNG, JPG, SVG, EPS, and PDF, with transparent backgrounds and variations for digital and print use. Beyond logos, Design.com ...

After hours: January 31 at 7:59:52 p.m. EST ...

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

UN Women Regional Director for Asia and the Pacific, Christine Arab, concluded a four-day visit to Papua New Guinea (PNG), reaffirming the organization’s commitment to supporting the Government of PNG ...